EUVIMEDEUVIMED entdecken
Open Access

KIM-1 as a Prognostic Marker in Renal Cell Carcinoma

Clara Steiner, Marc Machaalani, Joseph V Bonventre, David F McDermott, Toni K Choueiri, Wenxin Xu

European Urology Focus · 2025

DOI: 10.1016/j.euf.2025.06.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Urology Focus, 2025. Verfasst von Clara Steiner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Hepatitis A Virus Cellular Receptor 1, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is an unmet need for a noninvasive biomarker in renal cell carcinoma. KIM-1 has emerged as a compelling candidate according to retrospective evidence and post hoc analyses of prospective trials. Prospective studies are needed for validation and clinical implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellHepatitis A Virus Cellular Receptor 1Kidney NeoplasmsBiomarkers, TumorHumansPrognosis

Substanzen

Hepatitis A Virus Cellular Receptor 1HAVCR1 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA; Brigham and Women's Hospital, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address: wenxin_xu1@dfci.harvard.edu.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • US Office of Congressionally Directed Medical Research Programs

Zitieren

APA

Steiner, C., Machaalani, M., Bonventre, J. V., McDermott, D. F., Choueiri, T. K., & Xu, W. (2025). KIM-1 as a Prognostic Marker in Renal Cell Carcinoma. European Urology Focus. https://doi.org/10.1016/j.euf.2025.06.012

Vancouver

Steiner C, Machaalani M, Bonventre JV, McDermott DF, Choueiri TK, Xu W. KIM-1 as a Prognostic Marker in Renal Cell Carcinoma. European Urology Focus. 2025. doi:10.1016/j.euf.2025.06.012

BibTeX
@article{Steiner2025,
  author = {Steiner, Clara and Machaalani, Marc and Bonventre, Joseph V and McDermott, David F and Choueiri, Toni K and Xu, Wenxin},
  title = {KIM-1 as a Prognostic Marker in Renal Cell Carcinoma},
  journal = {European Urology Focus},
  year = {2025},
  doi = {10.1016/j.euf.2025.06.012}
}
Kostenlos starten →